Biomechanical and Histological Effects of Augmented Soft Tissue Mobilization Therapy on Achilles Tendinopathy in a Rabbit Model  by Imai, Kan et al.
BIOMECHANICAL AND HISTOLOGICAL EFFECTS OF
AUGMENTED SOFT TISSUE MOBILIZATION
THERAPY ON ACHILLES TENDINOPATHY IN A
RABBIT MODEL
Kan Imai, MD, PhD, a Kazuya Ikoma, MD, PhD,a Qingshan Chen, MS, b Chunfeng Zhao, MD, c
Kai-Nan An, PhD, d and Ralph E. Gay, MD, DCeA
a Research Fe
Rochester, MN.
b Engineer, Ma
MN.
c Professor, M
MN.
d Professor and
Rochester, MN.
e Associate Pr
Medicine and Re
Submit reque
Associate Profess
SW, Rochester, M
Paper submitt
2014; accepted D
0161-4754
Copyright © 2
http://dx.doi.o
Open access undABSTRACTObjective: Augmented soft tissue mobilization (ASTM) has been used to treat Achilles tendinopathy and is thought to
promote collagen fiber realignment and hasten tendon regeneration. The objective of this study was to evaluate the
biomechanical and histological effects of ASTM therapy on rabbit Achilles tendons after enzymatically induced injury.
Methods: This study was a non-human bench controlled research study using a rabbit model. Both Achilles tendons
of 12 rabbits were injected with collagenase to produce tendon injury simulating Achilles tendinopathy. One side was
then randomly allocated to receive ASTM, while the other received no treatment (control). ASTM was performed on
the Achilles tendon on postoperative days 21, 24, 28, 31, 35, and 38. Tendons were harvested 10 days after treatment
and examined with dynamic viscoelasticity and light microscopy.
Results: Cross-sectional area in the treated tendons was significantly greater than in controls. Storagemodulus tended to
be lower in the treated tendons but elasticity was not significantly increased. Loss modulus was significantly lower in the
treated tendons. There was no significant difference found in tangent delta (loss modulus/storage modulus). Microscopy
of control tendons showed that the tendon fibers were wavy and type III collagen was well stained. The tendon fibers of
the augmented soft tissue mobilization treated tendons were not wavy and type III collagen was not prevalent.
Conclusion: Biomechanical and histological findings showed that the Achilles tendons treated with ASTM had better
recovery of biomechanical function than did control tendons. (J Manipulative Physiol Ther 2015;38:112-118)
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.study with 11 years of follow-up, Kujala et al.3 reported
that 29% of 269 male orienteering runners and 4% of 188
controls had experienced an Achilles tendon overuse injury;
the age-adjusted odds ratio was 10.0 in runners compared
with controls. Achilles tendinopathy causes many patients
to decrease their physical activity, with a potentially negative
effect on their overall health and well-being.4,5 Despite rest
from sports activities and various conservative treatments,
many patients continue to have symptoms. The need for
surgery increases with patient age, duration of symptoms,
and changes in tendinopathy.6 The results of operative
treatment for Achilles tendinopathy are usually good.7–11
However, postoperative complications often contribute to
impairment and delayed recovery.9–11
Massage is one of the oldest forms of therapy for
musculoskeletal disorders. Several forms of massage or soft
tissue mobilization techniques have been developed and
used for chronic Achilles tendon overuse injuries. Aug-
mented soft tissue mobilization (ASTM) is a modification
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designed solid instruments to provide the contact force on
the tendon. In the only published clinical trial of ASTM,
Wilson et al.12 compared ASTM with a traditional physical
therapy regime for patellar tendinitis. ASTM treatment was
superior (100% vs 60% symptom resolution). ASTM is
commonly used for Achilles tendinitis although no clinical
trials have been reported. It has been shown to result in
morphologic changes in the tendon in at least 2 animal
studies.13,14 Davidson et al.13 suggested that ASTM may
promote healing via increased fibroblast recruitment.
Gehlsen et al.14 suggested that applying heavy pressure
promotes the healing process to a degree greater than use of
light or moderate pressure. Both studies showed that ASTM
increased the number of fibroblasts and activated fibro-
blasts. Thus, ASTM theoretically increases the synthesis of
collagen and might change the biomechanical properties of
the tendon. However, there are no reports of the effect of
ASTM on the biomechanical properties of injured
Achilles tendons.
There are no published guidelines regarding the
recommended dose of ASTM for Achilles tendinitis in
humans. Proponents of ASTM have noted that an average
of 8 treatments resulted in 77% excellent results (at least
90% symptom resolution) and 15% good results
(80%-90% symptom resolution).15 Histological changes
have been reported in a rat model after 4 to 6
treatments13,14 and the amount of pressure applied during
treatment was noted to correlate with the amount of
organized rough endoplasmic reticulum in the healing
tendon (indicative of protein synthesis).14
During rehabilitation after Achilles tendon overuse injury,
the tendon is subjected to both static and dynamic loads
during walking, running, and jumping. Therefore, it is
necessary to assess not only static but dynamic biomechanical
properties. Studies assessing viscoelastic properties of soft
tissues have primarily used static testing,16–19 but we have
not found reports assessing the biomechanical properties
of Achilles tendon by dynamic viscoelastic testing. While
creep17 and stress-strain20,21 have often been used as static
viscoelastic tests, the rate of change with stress and strain is
slow, and there are no reports of chronological change.
Dynamic mechanical analysis measures viscoelastic
properties by repeatedly applying sine wave stress at
various frequencies to a tendon sample while measur-
ing the dynamic strain response. The storage modulus
(E′) is an indicator for the elastic component
representing energy storage, while the loss modulus
(E′′) is an indicator for the viscous component of the
tissue which dissipates the mechanical energy and
converts it to heat. Tangent delta (tan δ) is calculated
by dividing E′′ by E′. 22,23 Thus, dynamic viscoelastic
testing can ascertain the dynamic mechanical response
of the Achilles tendon to mechanical perturbations that
reflect activities of daily living.The purpose of this study was to evaluate the effect of
ASTM therapy on healing in a rabbit model of Achilles
tendinopathy by quantifying dynamic biomechanical prop-
erties and examining histological features.METHODS
Both Achilles tendons of 12 male New Zealand white
rabbits (mean weight 3.53 +/- 0.06 kg) were injected with
collagenase to produce tendon injury simulating Achilles
tendinopathy. One hind leg of each rabbit was randomly
assigned to treatment with ASTM while the other served as
a control. This protocol was approved by the Mayo Clinic
Institutional Animal Care and Use Committee. All animals
were monitored for adverse effects by animal care staff.Achilles Tendon Injury Model
The Achilles tendons of the 12 rabbits were injected with
collagenase to induce tendinopathy.24,25 The direct injection
of collagenase provided a good model of tendinosis because
connective tissue natively contains collagen and levels of
collagenase rise after injury. Prior to the injection, the animals
were anesthetized intramuscularly with a cocktail solution of
ketamine (70 mg/mL), acepromazine (2 mg/mL), and
xylazine (10 mg/mL) at a dosage of 0.6 mL/kg of body
mass. A longitudinal incision was made slightly medial to the
outline of the Achilles tendon. The Achilles tendon was
exposed 1 cm proximal to the calcaneal insertion. Under
direct visualization, 30 μL of collagenase (10 mg/mL) were
injected into the center of the tendon. The incision was closed
with simple sutures. The rabbits were returned to cage activity
after surgery. The surgical site was allowed to heal for
3 weeks before beginning treatment.
Although the treatment was expected to produce minimal
if any discomfort, the animals were monitored for signs of
pain before, during, and after the collagenase injection and
throughout the study using published guidelines.26Augmented Soft Tissue Mobilization
The animals underwent ASTM using a custom-made
stainless steel instrument (Graston Technique, Indianapolis,
Indiana) to apply mobilization force to the Achilles tendon.
To administer ASTM, animals were placed in a prone
position with the foot elevated to allow access to the
Achilles tendon. An assistant gently held the animals body
and steadied the lower limbs while the investigator applying
the treatment held the foot of the side being treated to assure
minimal movement of the animal. Prior to administering
treatment, the treating person practiced consistently apply-
ing 1.5 N/mm2 pressure to tendon as measured by a force
sensor (K-Scan System sensor model 6900; Tekscan, Inc,
South Boston, Massachusetts), with real-time feedback to
help maintain the target contact force. The animals were
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present in the Achilles tendon. Pressure was applied to one
Achilles tendon of each rabbit using 3 strokes in each
direction with approximately 1.5 N/mm2 pressure. Each
treatment lasted approximately 3 minutes. The tendon was
massaged moving distal to proximal, then proximal to distal
along the length of the tendon. Care was taken not to break
the overlying skin. ASTM was performed on postoperative
days 21, 24, 28, 31, 35, and 38 for 6 treatments. The rabbits
were allowed to move normally within their cages between
treatments.Dynamic Viscoelasticity Testing
Ten days after the last ASTM treatment the animals were
sacrificed and the lower limbs amputated superior to the knee
joint. The area of tendon damage was excised along with
margins of normal tissue at each end and eachwas prepared for
biomechanical testing with ample margins of proximal and
distal normal tendon. Viscoelasticity of each tendon was
measured using dynamic mechanical analysis (Bose Electro-
Force Systems Group, Eden Prairie, Minnesota). The normal
ends of tendon were grasped with clamps and mounted in the
tester (Fig 1). The initial length of the tendonwas defined as the
grip length at a static tensile pre-load of 1 N. A cyclic tensile
strain of 1%was applied tomeasure the strain (ε) and stress (σ)
by varying the frequency of dynamic load at 0.1, 0.5, 1.0, 5.0,
and10 Hz. Storage modulus (E′), loss modulus (E′′), and loss
tangent (tan δ) were derived using the following formula:
ε ¼ ε0▪ sinωt ε0 : peak strain; ω : angular velocityð Þ
σ ¼ σ0▪ sin ωt – δð Þ σ0 : maximal stress; δ : phase differenceð Þ
Ej j ¼ σ0=ε0 Pað Þ
E0 ¼ Ej j cos δ Pað Þ E0 : dynamic storage modulusð Þ
E” ¼ Ej j sin δ Pað Þ E00 : dynamic loss modulusð Þ
tan δ ¼ E00=E0
Cross-sectional Area
The diameter of the center part of the injured Achilles
tendon was measured, and the cross-sectional area
calculated. To calculate the cross-sectional area of each
tendon we assumed an elliptical shape and measured the
long and short axis of each tendon with digital calipers.
Those measurements were then multiplied.Light Microscopy Examination
Two treated specimens and 2 control specimens were
examined with light microscopy to determine the alignment
of collagen and quantify the number of tenocytes present.
The specimens were fixed with 10% formaldehyde (pH 7.4)
and embedded in paraffin. Sections were cut at a thickness
of 3 μm in a plane parallel to the longitudinal axis of the
tendon. The sections were stained with hematoxylin-eosin
(HE) and type I and III collagen primer antibody.Statistical Analysis
The E′, E′′, tan δ and tendon cross-sectional area of the
treated tendons were compared with those of the untreated
tendons using paired t tests. A P value of less than 0.05 was
considered statistically significant.
Fig 1. Viscoelastic testing of the Achilles tendon.RESULTS
Cross-sectional Area
The mean ± SD cross-sectional area of the treated tendons
was greater than the control tendons andwas 12.30 ± 5.47mm2
and 9.57 ± 8.36 mm2, respectively (P b .01) (Fig 2).Dynamic Viscoelastic Testing
At all dynamic loading frequencies, the storage modulus
(E′) in the control tendons was higher than in the treated
tendons but it was statistically significant only at 0.1 Hz and
10 Hz (P = .05) (Fig 3). The loss modulus (E′′) was
significantly lower in the treated tendons than in the control
tendons (P b .05) (Fig 4). There was no significant
difference in loss tangent (tan δ) between the treated and
control tendons (Fig 5).Light Microscopy
HE staining showed that the tendon fibers in the control
tendons were wavy and kinking and displayed a disordered
collagen arrangement. In contrast, the fibers of the tendons
treated with ASTM were well aligned (Fig 6). Immunohis-
tochemical staining demonstrated higher color intensity of
Fig 2. Cross-sectional area. There were significant differences
between the treated and untreated tendons (means, SDs). ASTM
augmented soft tissue mobilization.
Fig 3. Storage modulus. At all dynamic loading frequencies, E′ in
untreated tendons was higher than in treated tendons (means, and
SDs). ASTM, augmented soft tissue mobilization. *P b .05.
Fig 4. Loss modulus. There were significant differences between
treated and untreated tendons (means, SDs). ASTM, augmented
soft tissue mobilization. *P b .05; **P b .01.
Fig 5. Loss tangent. Therewas no significant difference between treated
and untreated tendons. ASTM, augmented soft tissue mobilization.
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treated tendons (Fig 7).DISCUSSION
Achilles tendinopathy is a chronic degenerative condi-
tion that frequently does not respond to conservative
treatments such as rest, training modification, traditional
physical therapy, nonsteroidal anti-inflammatory medica-
tions, and corticosteroid injections. Numerous treatments
have been proposed to promote healing of this injury. Cell
therapy and mesenchymal stem cell therapy have been
described.27–29 Several studies in animals30,31 and in
humans32,33 have shown that extracorporeal shockwave
therapy may be an effective treatment. Low laser therapy
has been suggested as it has modulatory effects on
inflammatory markers, reducing the inflammatory process,
and modulating leukocyte activity in both animals and
humans.34,35 The mechanical effects of treatments for
Achilles tendinopathy have not been routinely studied.Nagasawa et al.36 measured viscoelasticity of Achilles
tendons 3 weeks after tenotomy and found the Young
modulus and tangent delta to be lower in tenotomy specimens
than in control specimens. We found no reports of dynamic
mechanical analysis after tenotomy or surgical repair.
ASTM therapy has been advocated for Achilles
tendinopathy with a few reports of its histological effects
in animal models. To our knowledge, there have been no
reports of its effect on the dynamic behavior of Achilles
tendon.12–14 We therefore sought to determine its effects on
the biomechanical behavior of healing Achilles tendon. We
found that ASTM resulted in greater viscosity in treated
tendons compared with the control tendons in a rabbit
model. Elasticity increased also but it was not statistically
significant. Because both elasticity and viscosity increased
there was no significant difference in tangent delta between
the treated and control tendons. Nonetheless, the treated
tendons may be stronger than the untreated tendons because
of the increases observed in the cross-sectional area and
dynamic viscoelasticity.
We used collagenase to induce an injury and simulate a
chronic degenerative clinical condition. There may be other
models that better demonstrate aspects of the pathology
seen in chronic tendinopathy. The ASTM therapy started 3
ig 6. Hematoxylin-eosin stain, magnification × 400. A, Norma
chilles tendon. B, ASTM treated tendon. C, Untreated tendon.
ig 7. Type III collagen stain, magnification × 200. A, ASTM
eated tendon. B, Untreated tendon.
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Alweeks after injection, as done by Chen et al.27 The results
indicated that rabbits injected with collagenase had clear
degenerative changes consistent with advancing tendino-
pathy, including fiber disruption, fiber mal arrangement,
angiogenesis, and micronucleation by 10 weeks. Waiting
longer than 3 weeks before starting treatment might haveF
trresulted in more degenerative change reflective of the
clinical condition.
We performed exploratoryHE staining in a few specimens
which showed that the tendon fiber in the control tendonswas
wavy and kinking with a disordered collagen arrangement.
The tendon fibers were well aligned in the tendons treated
with ASTM.Type III collagen color intensity in the
specimens examined in ASTM group was lower compared
to the control tendons examined. This suggests that the
remodeling phase with conversion of Type III to Type I
collagen occurred quicker in the ASTM treated tendons with
less granulation tissue formation. These observations are
similar to the findings in previous studies.13,14 Chen
et al.27,37 used histologic evaluation scores to assess the
effect of treatment in an Achilles tendinopathy rabbit model.
In that study HE staining showed that collagen fibers in
treated tendons were oriented in a parallel pattern, with slight
splitting between bundles and immunochemical chemistry
staining found the type III collagen intensity index to be
similar among 3 treatment groups.
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current study suggest that the tendons treatedwithASTMwere
in the process of healing and the untreated control tendons
remained in a state consistent with chronic inflammation.LIMITATIONS
The present study has several limitations. We performed
viscoelasticity testing and histology at 10 days after
completion of therapy as done in previous studies by Chen
et al.13,14 Nagasawa et al.36 measured these characteristics at
3, 6, and 12 weeks and showed the cross-sectional area was
smaller and the Young modulus was larger with each week
that passed. Although we found differences suggesting
benefit 10 days after stopping treatment, the effects of
ASTM should be evaluated over a longer time period in
future studies.
Although we completed microscopy on a few speci-
mens, we did not do it on all specimens and did not grade
the findings as an outcome measure. Our histological results
are exploratory and must be weighed accordingly. Future
studies of ASTM should use an objective score or index27
to judge histological results.CONCLUSION
We found that ASTM had a measureable beneficial effect
on the dynamic biomechanical behavior of healing Achilles
tendons in a rabbit model of Achilles tendinopathy.Practical Applications
• Augmented soft tissue mobilization (ASTM)
of injured Achilles tendons in a rabbit model
resulted in better recovery of biomechanical
function than did no treatment.
• Loss modulus of the treated tendons was
significantly lower and cross-sectional area of
the treated tendons was significantly greater
than in controls.
• ASTMmay result in improved clinical results
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